Treatment for Castleman's disease varies depending on the type of disease and the presence of specific infections like HHV-8 or HIV. Surgical removal is the primary treatment for Unicentric Castleman Disease, which can cost somewhere between Rs. 20,000 and Rs. 50,000, depending on the doctor’s experience and the patient’s condition. For Multicentric Castleman Disease, systemic therapies like monoclonal antibodies and antivirals are preferred
Castleman’s disease is a rare non-clonal lymphoproliferative disorder characterized by abnormal lymph node growth and systemic inflammation. It can be classified into two main forms: unicentric and multicentric. Unicentric means affecting a single lymph node region, whereas multicentric means affecting multiple lymph node regions.
Treatment and prognosis vary significantly between these two forms. In this section, we will discuss different therapies to treat this condition:
Complete surgical excision of the affected lymph node is the most preferred and often curative treatment. If surgery is not possible or if the disease recurs, doctors recommend radiation therapy, which can cost somewhere between Rs. 60,000 and Rs. 3,00,000.
These are some of the treatment approaches for MCD:
Uricentric Castleman disease typically resolves with the surgical removal of the affected lymph node, but can rarely lead to paraneoplastic pemphigus (PNP) or bronchiolitis obliterans (BO). On the other hand, multicentric Castleman disease (MCD) can cause serious complications, such as life-threatening infections, organ failure, and increased risk of lymphoma and Kaposi’s sarcoma.
Castleman's disease can be challenging to diagnose due to its similarity to other illnesses like non-Hodgkin lymphoma and angioimmunoblastic T-cell lymphoma. It is important to consult with haematologists or oncologists who are experienced in treating Castleman’s disease to get proper consultation regarding treatment plans.